By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ARMO BioSciences 

Redwood City  California    U.S.A.
Phone: n/a Fax: n/a



Company News
ARMO BioSciences Presents Clinical Data On Immunotherapy AM0010 In Advanced Pancreatic Cancer At ESMO World Congress On Gastrointestinal Cancer 2017 6/29/2017 8:44:50 AM
ARMO BioSciences Appoints Naiyer A. Rizvi, M.D. To Board Of Directors 6/28/2017 7:43:57 AM
ARMO BioSciences Announces Promising Response Rates And Survival Data In Patients With Advanced NSCLC And RCC From Phase I/Ib Trial For Immunotherapy AM0010 With Checkpoint Inhibitors 6/5/2017 6:19:23 AM
ARMO BioSciences Announces Encouraging Survival Data Observed In Patients With Advanced Pancreatic Cancer In Phase I/Ib Trial Of Immunotherapy AM0010 6/5/2017 6:15:24 AM
ARMO BioSciences To Present At The Jefferies 2017 Global Healthcare Conference 5/30/2017 11:30:11 AM
ARMO BioSciences Appoints Pierre Legault To Board Of Directors 4/26/2017 9:17:30 AM
ARMO BioSciences Announces Clinical Data Presentation For Immunotherapy AM0010 At The 12th European International Kidney Cancer Symposium 4/21/2017 10:39:55 AM
ARMO BioSciences Announces Clinical Data Presentations For Immunotherapy AM0010 At ASCO 2017 Annual Meeting 4/20/2017 1:29:42 PM
ARMO BioSciences Announces First Patient Dosed In Pivotal Phase III Trial Of Immunotherapy AM0010 For Advanced Pancreatic Cancer 3/29/2017 6:35:20 AM
ARMO BioSciences Release: Company Presents New Phase Ib Clinical Data For AM0010 In Advanced Pancreatic Cancer Patients At 2017 Gastrointestinal Cancers Symposium 1/20/2017 8:14:55 AM